Federica Pecci, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a paper she co-authored with colleagues published in Clinical Cancer Research,:
“Just published in Clinical Cancer Research, our work studying factors associated with prolonged disease control and survival after discontinuation of immune checkpoint inhibitors for irAEs in patients with advanced NSCLC.”
Authors: Federica Pecci, Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao Alessi, Mizuki Nishino, Bruce Johnson, Matthew Hellmann, Adam Schoenfeld, Mark Awad et al.
More posts featuring Federica Pecci.